These findings suggest that the ILK–GSK3β–ZEB1 pathway is important in regulating the EMT in bladder cancer through the regulation of E-cadherin and potentially other pathways associated with ILK regulation [144]. The gene discussed is CDH1; the disease is urinary bladder carcinoma.